RxSight, Inc. (RXST)Healthcare | Medical Devices | Aliso Viejo, United States | NasdaqGM
7.05 USD
+0.44
(6.657%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 7.07 +0.02 (0.237%) ⇧ (Aug. 28, 2026, 7:40 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:07 a.m. EDT
The investment case here is fundamentally broken despite the recent price bounce. The company is burning cash aggressively, with operating cash flow and free cash flow both deeply negative, while returning millions in equity to executives via RSUs and options. The balance sheet is fragile, with debt significantly outweighing equity, and the business is failing to generate returns on assets or equity. Although the stock recently rallied off its lows, the underlying economics remain unsustainable without a major turnaround. The options market confirms this fear, with traders stacking heavy protection at lower price levels rather than betting on continued upside. The recent surge appears to be a temporary relief rally rather than a reversal of the deteriorating trend. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.123215 |
| AutoETS | 0.141670 |
| AutoARIMA | 0.141672 |
| AutoTheta | 0.275810 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 16.16 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.411 |
| Excess Kurtosis | -0.97 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 4.018 |
| Revenue per Share | 3.094 |
| Market Cap | 293,232,448 |
| Forward P/E | -10.12 |
| Beta | 1.13 |
| Profit Margins | -36.80% |
| Website | https://rxsight.com |
As of Aug. 22, 2026, 3:07 a.m. EDT: Speculators are heavily positioned for downside protection, evidenced by massive open interest in deep out-of-the-money puts (strikes at 20% and 60% below current price) compared to negligible call volume. While there is some recent call volume at strikes above the current price, the overwhelming capital allocation is in put writing or buying, suggesting a consensus expectation of further price weakness or a 'sell the news' event following the recent rally.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.18965518 |
| Address1 | 100 Columbia |
| All Time High | 66.54 |
| All Time Low | 4.48 |
| Ask | 7.8 |
| Ask Size | 2 |
| Audit Risk | 3 |
| Average Daily Volume10 Day | 801,070 |
| Average Daily Volume3 Month | 1,143,353 |
| Average Volume | 1,143,353 |
| Average Volume10Days | 801,070 |
| Beta | 1.132 |
| Bid | 4.45 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 6.333 |
| City | Aliso Viejo |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.05 |
| Current Ratio | 4.07 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 7.06 |
| Day Low | 6.55 |
| Debt To Equity | 4.018 |
| Display Name | RxSight |
| Earnings Call Timestamp End | 1,785,961,800 |
| Earnings Call Timestamp Start | 1,785,961,800 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,793,822,400 |
| Earnings Timestamp Start | 1,793,822,400 |
| Ebitda | -51,575,000 |
| Ebitda Margins | -0.40425 |
| Enterprise To Ebitda | -1.842 |
| Enterprise To Revenue | 0.745 |
| Enterprise Value | 95,013,456 |
| Eps Current Year | -0.27472 |
| Eps Forward | -0.69696 |
| Eps Trailing Twelve Months | -1.14 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.8172 |
| Fifty Day Average Change | 1.2328 |
| Fifty Day Average Change Percent | 0.21192326 |
| Fifty Two Week Change Percent | -18.965519 |
| Fifty Two Week High | 13.22 |
| Fifty Two Week High Change | -6.17 |
| Fifty Two Week High Change Percent | -0.4667171 |
| Fifty Two Week Low | 4.48 |
| Fifty Two Week Low Change | 2.5700002 |
| Fifty Two Week Low Change Percent | 0.57366073 |
| Fifty Two Week Range | 4.48 - 13.22 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,627,651,800,000 |
| Float Shares | 33,769,149 |
| Forward Eps | -0.69696 |
| Forward P E | -10.115358 |
| Free Cashflow | -6,730,375 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 461 |
| Fullday Change | 0.44000006 |
| Fullday Change Percent | 6.656582 |
| Fullday Price | 7.0667 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.77499 |
| Gross Profits | 98,875,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.06418 |
| Held Percent Institutions | 1.0053 |
| Implied Shares Outstanding | 41,593,256 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-07-30 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California. |
| Long Name | RxSight, Inc. |
| Market | us_market |
| Market Cap | 293,232,448 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_62603649 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -46,949,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 274,931,422 |
| Number Of Analyst Opinions | 8 |
| Open | 6.59 |
| Operating Cashflow | -22,732,000 |
| Operating Margins | -0.40811002 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 949 521 7830 |
| Post Market Change | 0.016699791 |
| Post Market Change Percent | 0.23687646 |
| Post Market Price | 7.0667 |
| Post Market Time | 1,787,960,419 |
| Previous Close | 6.61 |
| Price Eps Current Year | -25.662493 |
| Price Hint | 2 |
| Price To Book | 1.1132165 |
| Price To Sales Trailing12 Months | 2.2983842 |
| Profit Margins | -0.36799 |
| Quick Ratio | 3.572 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.44000006 |
| Regular Market Change Percent | 6.656582 |
| Regular Market Day High | 7.06 |
| Regular Market Day Low | 6.55 |
| Regular Market Day Range | 6.55 - 7.06 |
| Regular Market Open | 6.59 |
| Regular Market Previous Close | 6.61 |
| Regular Market Price | 7.05 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 663,387 |
| Return On Assets | -0.10411 |
| Return On Equity | -0.17345 |
| Revenue Growth | 0.003 |
| Revenue Per Share | 3.094 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 41,593,256 |
| Shares Percent Shares Out | 0.1024 |
| Shares Short | 4,260,075 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 3,841,752 |
| Short Name | RxSight, Inc. |
| Short Percent Of Float | 0.108100004 |
| Short Ratio | 4.39 |
| Source Interval | 15 |
| State | CA |
| Symbol | RXST |
| Target High Price | 11.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 7.7875 |
| Target Median Price | 6.75 |
| Total Cash | 208,799,008 |
| Total Cash Per Share | 5.02 |
| Total Debt | 10,580,000 |
| Total Revenue | 127,582,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.14 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.630575 |
| Two Hundred Day Average Change | -0.580575 |
| Two Hundred Day Average Change Percent | -0.07608535 |
| Type Disp | Equity |
| Volume | 663,387 |
| Website | https://rxsight.com |
| Zip | 92,656 |